Skip to content

Antepartum Cardiotocography With and Without Computer Analysis in High Risk Pregnancies

Antepartum Cardiotocography With and Without Computer Analysis in High Risk Pregnancies

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03862976
Enrollment
28
Registered
2019-03-05
Start date
2019-03-25
Completion date
2020-03-23
Last updated
2020-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section

Brief summary

Electronic fetal hear rate monitoring (EFM), or cardiotocography (CTG), records changes in fetal heart rate and their temporal relationship to uterine contraction. It has been developed with the aim of detecting fetal hypoxia during labor and hence to prevent metabolic acidosis. Despite being the standard for intrapartum management, this technique, significantly increase the operative delivery rate, and is associated only with less seizures as neonatal benefit. Another concern is also the variability in the interpretation. Several techniques have been studied in order to decrease the high false positive rate. Fetal ST waveform analysis (STAN) has been studied combined with CTG. A recent meta-analysis of randomized trials, however, showed that STAN during labor did not improve perinatal outcomes or decrease operative delivery rates, except for a 9% decrease in operative vaginal delivery.Comparisons of visual and computerized interpretation of EFM have also been reported. However, whether or fetal monitoring with computer analysis improve perinatal outcomes is still subject of debate. Thus, we aim to evaluate whether intrapartum fetal monitoring with computer analysis increase the incidence of obstetric intervention when compared with visual analysis through a single-center randomized controlled trial.

Interventions

computerized cardiotocography (C-CTG)

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Women with singleton gestation * 18 years to 50 years * High risk pregnancies: DM, or GDM, or hypertension, or preeclampsia

Exclusion criteria

\- IUGR

Design outcomes

Primary

MeasureTime frameDescription
cesarean sectionat the time of deliveryincidence of cesarean section

Secondary

MeasureTime frameDescription
gestational age at deliveryat the time of deliveryweek of delivery
admission to neonatal intensive care unitat the time of deliveryadmission to neonatal intensive care unit
birth weightat the time of deliveryneonatal birth weight at delivery
APGAR score at deliveryat the time of deliveryAPGAR score at delivery
neonatal death28 days of live of the neonatedeath of a live neonates within 28 days of life

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026